Fort Pitt Capital Group LLC boosted its holdings in Colgate-Palmolive (NYSE:CL) by 0.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,785 shares of the company’s stock after purchasing an additional 19 shares during the quarter. Fort Pitt Capital Group LLC’s holdings in Colgate-Palmolive were worth $725,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. Dynamic Technology Lab Private Ltd acquired a new position in Colgate-Palmolive in the second quarter valued at $654,000. WINTON GROUP Ltd increased its stake in Colgate-Palmolive by 162.7% in the second quarter. WINTON GROUP Ltd now owns 476,623 shares of the company’s stock valued at $35,332,000 after purchasing an additional 295,217 shares during the last quarter. Covington Capital Management increased its stake in Colgate-Palmolive by 3.9% in the second quarter. Covington Capital Management now owns 137,470 shares of the company’s stock valued at $10,191,000 after purchasing an additional 5,206 shares during the last quarter. Colony Group LLC increased its stake in Colgate-Palmolive by 7.5% in the second quarter. Colony Group LLC now owns 17,419 shares of the company’s stock valued at $1,291,000 after purchasing an additional 1,219 shares during the last quarter. Finally, National Asset Management Inc. increased its stake in Colgate-Palmolive by 3.6% in the second quarter. National Asset Management Inc. now owns 8,927 shares of the company’s stock valued at $663,000 after purchasing an additional 311 shares during the last quarter. Hedge funds and other institutional investors own 72.96% of the company’s stock.

Several brokerages have commented on CL. Societe Generale lowered Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Wednesday, November 8th. Citigroup dropped their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research note on Thursday, November 2nd. Finally, Morgan Stanley dropped their price target on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, October 31st. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $76.04.

In related news, insider Victoria L. Dolan sold 9,000 shares of the stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total value of $660,690.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Victoria L. Dolan sold 10,000 shares of the stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the transaction, the insider now directly owns 60,528 shares of the company’s stock, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 173,673 shares of company stock valued at $12,629,293. Insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive (CL) opened at $73.32 on Monday. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.27. The stock has a market capitalization of $64,382.68, a PE ratio of 25.55, a PEG ratio of 3.36 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter last year, the firm earned $0.73 earnings per share. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. analysts expect that Colgate-Palmolive will post 2.88 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were paid a $0.40 dividend. The ex-dividend date was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.18%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 61.78%.

COPYRIGHT VIOLATION WARNING: “Fort Pitt Capital Group LLC Buys 19 Shares of Colgate-Palmolive (CL)” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/12/11/fort-pitt-capital-group-llc-buys-19-shares-of-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.